key: cord-0934700-w1rze4tw authors: Goff, Debra A.; Ashiru‐Oredope, Diane; Cairns, Kelly A.; Eljaaly, Khalid; Gauthier, Timothy P.; Langford, Bradley J.; Mahmoud, Sara Fouad; Messina, Angeliki P.; Michael, Ubaka Chukwuemeka; Saad, Thérèse; Schellack, Natalie title: Global contributions of pharmacists during the COVID‐19 pandemic date: 2020-10-02 journal: J Am Coll Clin Pharm DOI: 10.1002/jac5.1329 sha: ce576af6dd87dbf46f721d8900fb6ffa32ea016e doc_id: 934700 cord_uid: w1rze4tw Throughout the SARS‐CoV‐2 (COVID‐19) global pandemic, pharmacists were rarely mentioned as essential frontline health care providers by the news media, the public, or politicians. Around the world, pharmacists are working on the frontlines of health care every day providing essential health care services during the pandemic. Pharmacists are medication experts providing patient care in a variety of settings including hospitals, clinics, community pharmacies, long‐term care, physician offices, and national and public health. In this paper, we describe how pharmacists from high and low‐middle income countries contributed to essential patient care and well‐being of the public during the COVID‐19 pandemic. While the news media, the public, and politicians often overlooked pharmacists as essential frontline health care providers, we hope that this list of contributions by pharmacists from nine countries in this article can help to change this perspective. While the SARS-CoV-2 (COVID- 19) pandemic spread across the world, the World Health Organization (WHO), the news media, and others recognized physicians and nurses for their heroic frontline efforts. Pharmacists, however, were rarely mentioned. Around the world, pharmacists are working on the frontlines of health care every day providing essential health care services throughout the pandemic. Pharmacists are medication experts providing patient care in a variety of settings including hospitals, clinics, community pharmacies, long-term care, physician offices, and national and public health. Pharmacists are among the most accessible health care professionals, with 90% of Americans living within 5 miles of a community pharmacy. 1 As challenges from the COVID-19 pandemic mount, pharmacists are answering the call to action but are the public, the news media, or politicians aware of the contributions by pharmacists? In a recent editorial titled "Hero Clinical Pharmacists and the COVID -19 Pandemic: Overworked and Overlooked", Bauman states that in U.S. academic health centers, other health care providers acknowledge and champion pharmacists as valued team members; however, "this knowledge has not always been translated to the public, the news media, and politicians". 2 Cheong and colleagues published a pharmacist's "call to action" to commit to public action now to raise the bar for the public's expectations of how pharmacists contribute to the quality use of medications during the pandemic and chronic situations. 3 Pharmacy societies and organizations have provided numerous COVID-19 educational resources. (Table 1) To date, pharmacists from China, Australia, Malaysia, Saudi Arabia, and the United States (US) have described a variety of roles and contributions from pharmacists during the COVID-19 pandemic. [3] [4] [5] [6] [7] [8] [9] [10] Hospital pharmacists are evaluating emerging COVID-19 drug therapy options to rapidly make patient care decisions, monitoring and adjusting COVID-19 medications to prevent adverse side effects, managing numerous drug shortages, maintaining uninterrupted drug supply, resolving supply chain issues for critical care medicines, adjusting workflow to preserve personal protective equipment, and establishing new pharmacy services in temporary emergency COVID-19 hospitals. Experience from one U.S. hospital identified that COVID-19 patients received an average of 19.8 different medications and pharmacists made an average of eight interventions per patient. 6 A panel of U.S. physicians and six clinical pharmacists co-authored the National Institute of Health (NIH) treatment guidelines for COVID -19 intended for frontline health care providers caring for patients during the rapidly evolving pandemic. 11 Community pharmacists are setting up COVID-19 clinics, using telehealth to provide chronic care management, and providing COVID-19 testing and guidance once results are known. Pharmacists are also applying their extensive knowledge and training in medication use, management, and problem-solving to provide COVID-19 public health education to the public. The purpose of this article is to describe how pharmacists from selected high-and low-middle income countries contributed to essential patient care and the well-being of the public during the COVID-19 pandemic. Pharmacists from nine countries were selected based on previous antibiotic stewardship work with the senior author (DG) of this paper. She has worked globally with pharmacists across six continents and maintains interactions with this network of pharmacists through collaborations in research, publications, and use of social media. Figure 1 information. Twitter worked with the WHO, CDC, and academic institutions to identify experts to provide credible updates on the topic of COVID-19. 13 The ID pharmacist (@idpharmd) applied and received Twitter's blue badge "verification status" letting people know that the account of public interest is authentic. Importantly, five pharmacists on this paper received Twitter verification status to help provide accurate and reliable COVID-19 education to the public. Table 2 lists Twitter-verified accounts of selected ID pharmacists with over 2000 followers. In addition, we provide examples of COVID-19 pharmacy services from their place of work in Table 3 . IDStewardship is an online educational platform for ID pharmacists and antimicrobial stewardship. 14 Developed and managed by a U.S. ID Pharmacists also provided leadership and oversight into new public health roles and interventions ( In addition to those services included in Table 3 anti-inflammatory drugs, and intranasal medications in patients with From an antimicrobial stewardship perspective, an interdisciplinary team co-led by pharmacists is performing rapid reviews and meta-analyses on bacterial co-infection 19 Pharmacists participated in assisting South Africa's NDoH rapid review process to evaluate emerging therapies for COVID-19 to assist evidence-based medicine utilization. Further to this, pharmacists published a national COVID-19 guideline for pharmacists. 28 [cited 2020 June 21] . Available from: https://enugumetro.com/unthlaunches-testing-lab-isolation-centre-for-enugu/ 34. Adeogun A. Africa resource centre for supply chain 2020. Available from: http://www.phn.ng/africa-resource-centre-for-supply-chainarc-nigeria/ Executive summary pharmacists as front-line responders for Covid-19 patient care Hero clinical pharmacists and the COVID-19 pandemic: Overworked and overlooked COVID-19 and clinical pharmacy worldwide-A wake up call and a call to action Additional clinical pharmacists roles during COVID-19 Roles of clinical pharmacists during the COVID-19 pandemic Perspectives from the frontline: A pharmacy department's response to the COVID-19 pandemic Role of pharmacists during the COV ID-19 pandemic in China-Shanghai experiences Leveraging pharmacy residents during COVID-19 pandemic Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm The role of a Coronavirus disease 2019 pharmacist: an Australian perspective Coronavirus disease 2019 (COVID-19) treatment guidelines 2020 COVID-19 pandemic: challenges and solutions from the cardiology pharmacist's perspective Twitter prioritizes blue-check verifications to confirm experts on COVID-19 and the novel coronavirus COVID-19) resources for pharmacists 2020 Standards for registered pharmacies The Commonwealth Pharmacists Association's global response to COVID-19 Multi-site evaluation of partnered pharmacist medication charting and in-hospital length of stay COVID-19 What we know so far about use of non-steroidal anti-inflammatory drugs (NSAIDs) Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis Answers to Frequently Asked Questions about COVID-19 Treatment 2020 Clinical pharmacy in action ACCP members respond to the COVID-19 pandemic Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients Hydroxychloroquine safety: A meta-analysis of randomized controlled trials Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19 Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar The first consecutive 5000 patients with coronavirus disease 2019 from Qatar; a Nation-wide Cohort Study Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol COVID-19: guidelines for pharmacists in South Africa COVID-19: guidelines for pharmacists and the pharmacy workforce 2020 COVID-19 response in Lebanon: current experience and challenges in a low-resource setting Assessing knowledge, attitude, practice and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: A cross-sectional study Primary health care policy and vision for community pharmacy and pharmacists in Lebanon We acknowledge the following people for their input on the paper: